Tianjin TEDA Biomedical Engineering Company Limited (8189.HK)
HKD 0.28
(0.0%)
HKD 0.28
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -13.15 Million | -12.82 Million | -6.68 Million | 35.98 Million | -3.79 Million | -21.84 Million |
| Net Income | -17.61 Million | -26.49 Million | -44.83 Million | -50 Million | -88.81 Million | -300.47 Million |
| Depreciation & Amortization | 11.63 Million | 15.38 Million | 9.51 Million | 7.1 Million | 14.6 Million | 24.05 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -3.9 Million | -1.73 Million | -5.33 Million | 43.51 Million | 3.91 Million | 7.5 Million |
| Other non-cash items | -3.26 Million | 18.66 Thousand | 33.97 Million | 35.37 Million | 66.49 Million | 247.08 Million |
| Investing Cash Flow | -467.44 Thousand | -12.93 Million | -8.51 Million | -26.51 Million | 8.87 Million | -19.41 Million |
| Investments in PPE | -2.46 Million | -8.79 Million | -33.69 Million | -14.02 Million | -1.24 Million | -11.7 Million |
| Acquisitions | - | -6.38 Million | 1.13 Million | 1.08 Million | -2.73 Million | - |
| Investment purchases | - | - | -22.78 Million | -22 Million | -9 Million | - |
| Sales/Maturities of investments | 1.74 Million | 700 Thousand | 43.78 Million | -1.9 Million | 18.15 Million | - |
| Other Investing Activities | 253.12 Thousand | 1.54 Million | 3.04 Million | 10.33 Million | 3.68 Million | -7.7 Million |
| Financing Cash Flow | 12.72 Million | 6.16 Million | 28.1 Million | -20.19 Million | -23.95 Million | 46.78 Million |
| Debt repayment | -13.45 Million | -46.81 Million | -16 Million | -31.2 Million | -57.3 Million | -40 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | 39.8 Million |
| Other Financing Activities | 5.06 Million | 52.98 Million | 44.1 Million | 11 Million | 33.34 Million | 46.98 Million |
| Accounts receivables | 13.31 Million | -2.07 Million | 71.32 Thousand | -4.29 Million | -2.59 Million | 5.79 Million |
| Accounts payables | - | 2.07 Million | -71.32 Thousand | 4.29 Million | 2.59 Million | - |
| Inventory | -16.55 Million | 1.21 Million | 16.42 Million | -2.7 Million | -5.06 Million | -8.14 Million |
| Other working capital | 12.64 Million | -2.95 Million | -21.75 Million | 46.22 Million | 8.98 Million | 15.64 Million |
| Cash at beginning of period | 6.85 Million | 26.43 Million | 13.53 Million | 24.24 Million | 43.12 Million | 37.59 Million |
| Cash at end of period | 5.96 Million | 6.85 Million | 26.43 Million | 13.53 Million | 24.24 Million | 43.12 Million |
| Capital Expenditure | -2.46 Million | -8.79 Million | -33.69 Million | -14.02 Million | -1.24 Million | -11.7 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -893.31 Thousand | -19.58 Million | 12.9 Million | -10.71 Million | -18.88 Million | 5.53 Million |
| Free Cash Flow | -15.62 Million | -21.61 Million | -40.38 Million | 21.96 Million | -5.03 Million | -33.54 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.06 Million | -2.06 Million | -2.86 Million | -17.61 Million | -6.04 Million | -5.37 Million |
| Depreciation & Amortization | - | - | - | 11.63 Million | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | -3.9 Million | - | - |
| Other non-cash items | 6.08 Million | 6.08 Million | 2.86 Million | -3.26 Million | 6.04 Million | 5.37 Million |
| Investing Cash Flow | -374.37 Thousand | -374.37 Thousand | - | -467.44 Thousand | - | -1.45 Million |
| Investments in PPE | -374.37 Thousand | -374.37 Thousand | - | -2.46 Million | - | -1.45 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | 1.74 Million | - | - |
| Other Investing Activities | - | - | - | 253.12 Thousand | - | - |
| Financing Cash Flow | 2.48 Million | 2.48 Million | - | 12.72 Million | - | - |
| Debt repayment | - | - | - | -13.45 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 2.48 Million | 2.48 Million | - | 5.06 Million | - | - |
| Accounts receivables | - | - | - | 13.31 Million | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | -16.55 Million | - | - |
| Other working capital | - | - | - | 12.64 Million | - | - |
| Cash at beginning of period | - | - | - | 6.85 Million | - | 7.69 Million |
| Cash at end of period | 6.13 Million | 6.13 Million | - | 5.96 Million | - | 8.07 Million |
| Capital Expenditure | -374.37 Thousand | -374.37 Thousand | - | -2.46 Million | - | -1.45 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 6.13 Million | 6.13 Million | - | -893.31 Thousand | - | 375.19 Thousand |
| Free Cash Flow | 3.64 Million | 3.64 Million | - | -15.62 Million | - | 709.01 Thousand |
CBG
OASPW
6637
MTE
EQPA3
VLYPP